Wall Street Journal Newspaper Publishes Details Of Dr. Rath Research Institute’s Game-Changing Patent On Nutrient Combination For Inhibiting Coronavirus – Dr. Rath Health Foundation

The world’s first science-based micronutrient combination to be recognized by the United States Patent Office for preventing and treating SARS-CoV-2 infections, the revolutionary natural health technology developed by the Dr. Rath Research Institute simultaneously inhibits all pathways used by the coronavirus to infect the human body. Employing vitamin C, quercetin, baicalin, N-acetylcysteine, naringin, resveratrol, as well as extracts from broccoli, black tea, and turmeric, the institute’s approach to COVID-19 is fundamentally different to that followed by conventional medicine and its outdated reliance on pharmaceutical methodologies.

Right from the beginning of the pandemic, the Dr. Rath Research Institute’s scientists chose not to focus on developing vaccines against either the original (Wuhan) virus or one of its mutations. Instead, their approach is based on reducing the number of specific ‘doorway’ molecules (ACE2 receptors) in the human body through the use of particular combinations of micronutrients. All coronaviruses use ACE2 receptors in order to enter the cells of the lungs and other organs.

Following thorough tests, the micronutrient combination designed by the institute’s scientists has been found effective against all known mutations of SARS-CoV-2, including not just the original virus but also its Alpha, Beta, Delta, Gamma, Kappa, and Omega variants. Since all coronavirus variants use the same ACE2 receptor mechanism to infect human cells and the same enzymes to multiply inside them, the combination also seems likely to help prevent infections with future, as yet unknown, coronavirus variants.

Wall Street Journal Newspaper Publishes Details Of Dr. Rath Research Institute’s Game-Changing Patent On Nutrient Combination For Inhibiting Coronavirus – Dr. Rath Health Foundation